Selected research
Market Analysis & Forecast
Global Veterinary Infectious Disease Diagnosis Market Analysis and Forecast 2026-2032
Market perspective
The global Veterinary Infectious Disease Diagnosis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Veterinary Infectious Disease Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Veterinary Infectious Disease Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Veterinary Infectious Disease Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Veterinary Infectious Disease Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Veterinary Infectious Disease Diagnosis include Thermo Fisher Scientific, Neogen Corporation, Virbac, IDVet, Randox Laboratories, Heska Corporation, Creative Diagnostics, Eurofins Technologies and IDEXX Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Veterinary Infectious Disease Diagnosis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Veterinary Infectious Disease Diagnosis, also provides the revenue of main regions and countries. Of the upcoming market potential for Veterinary Infectious Disease Diagnosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Veterinary Infectious Disease Diagnosis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Infectious Disease Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Infectious Disease Diagnosis revenue, projected growth trends, production technology, application and end-user industry.
Veterinary Infectious Disease Diagnosis Segment by Company
Thermo Fisher Scientific
Neogen Corporation
Virbac
IDVet
Randox Laboratories
Heska Corporation
Creative Diagnostics
Eurofins Technologies
IDEXX Laboratories
Zoetis
QIAGEN
Veterinary Infectious Disease Diagnosis Segment by Type
Molecular Diagnostics
Immunodiagnostics
Other Technologies
Veterinary Infectious Disease Diagnosis Segment by Application
Veterinary Laboratories
Clinics
Reference Laboratories
Research Institutes
Others
Veterinary Infectious Disease Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Infectious Disease Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Infectious Disease Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Infectious Disease Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Veterinary Infectious Disease Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Veterinary Infectious Disease Diagnosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Infectious Disease Diagnosis revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Molecular Diagnostics
- Immunodiagnostics
- Other Technologies
Applications
- Veterinary Laboratories
- Clinics
- Reference Laboratories
- Research Institutes
- Others
Companies covered
- Thermo Fisher Scientific
- Neogen Corporation
- Virbac
- IDVet
- Randox Laboratories
- Heska Corporation
- Creative Diagnostics
- Eurofins Technologies
- IDEXX Laboratories
- Zoetis
- QIAGEN
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Veterinary Infectious Disease Diagnosis Market by Type
- 1.2.1 Global Veterinary Infectious Disease Diagnosis Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Molecular Diagnostics
- 1.2.3 Immunodiagnostics
- 1.2.4 Other Technologies
- 1.3 Veterinary Infectious Disease Diagnosis Market by Application
- 1.3.1 Global Veterinary Infectious Disease Diagnosis Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Veterinary Laboratories
- 1.3.3 Clinics
- 1.3.4 Reference Laboratories
- 1.3.5 Research Institutes
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Veterinary Infectious Disease Diagnosis Market Dynamics
- 2.1 Veterinary Infectious Disease Diagnosis Industry Trends
- 2.2 Veterinary Infectious Disease Diagnosis Industry Drivers
- 2.3 Veterinary Infectious Disease Diagnosis Industry Opportunities and Challenges
- 2.4 Veterinary Infectious Disease Diagnosis Industry Restraints
3 Global Growth Perspective
- 3.1 Global Veterinary Infectious Disease Diagnosis Market Perspective (2021-2032)
- 3.2 Global Veterinary Infectious Disease Diagnosis Growth Trends by Region
- 3.2.1 Global Veterinary Infectious Disease Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Veterinary Infectious Disease Diagnosis Market Size by Region (2021-2026)
- 3.2.3 Global Veterinary Infectious Disease Diagnosis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Veterinary Infectious Disease Diagnosis Revenue by Players
- 4.1.1 Global Veterinary Infectious Disease Diagnosis Revenue by Players (2021-2026)
- 4.1.2 Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Veterinary Infectious Disease Diagnosis Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Veterinary Infectious Disease Diagnosis Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Veterinary Infectious Disease Diagnosis Key Players Headquarters & Area Served
- 4.4 Global Veterinary Infectious Disease Diagnosis Players, Product Type & Application
- 4.5 Global Veterinary Infectious Disease Diagnosis Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Veterinary Infectious Disease Diagnosis Market CR5 and HHI
- 4.6.3 2025 Veterinary Infectious Disease Diagnosis Tier 1, Tier 2, and Tier 3
5 Veterinary Infectious Disease Diagnosis Market Size by Type
- 5.1 Global Veterinary Infectious Disease Diagnosis Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
- 5.3 Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Type (2021-2032)
6 Veterinary Infectious Disease Diagnosis Market Size by Application
- 6.1 Global Veterinary Infectious Disease Diagnosis Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
- 6.3 Global Veterinary Infectious Disease Diagnosis Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Thermo Fisher Scientific
- 7.1.1 Thermo Fisher Scientific Company Information
- 7.1.2 Thermo Fisher Scientific Business Overview
- 7.1.3 Thermo Fisher Scientific Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.1.4 Thermo Fisher Scientific Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.1.5 Thermo Fisher Scientific Recent Developments
- 7.2 Neogen Corporation
- 7.2.1 Neogen Corporation Company Information
- 7.2.2 Neogen Corporation Business Overview
- 7.2.3 Neogen Corporation Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.2.4 Neogen Corporation Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.2.5 Neogen Corporation Recent Developments
- 7.3 Virbac
- 7.3.1 Virbac Company Information
- 7.3.2 Virbac Business Overview
- 7.3.3 Virbac Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.3.4 Virbac Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.3.5 Virbac Recent Developments
- 7.4 IDVet
- 7.4.1 IDVet Company Information
- 7.4.2 IDVet Business Overview
- 7.4.3 IDVet Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.4.4 IDVet Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.4.5 IDVet Recent Developments
- 7.5 Randox Laboratories
- 7.5.1 Randox Laboratories Company Information
- 7.5.2 Randox Laboratories Business Overview
- 7.5.3 Randox Laboratories Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.5.4 Randox Laboratories Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.5.5 Randox Laboratories Recent Developments
- 7.6 Heska Corporation
- 7.6.1 Heska Corporation Company Information
- 7.6.2 Heska Corporation Business Overview
- 7.6.3 Heska Corporation Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.6.4 Heska Corporation Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.6.5 Heska Corporation Recent Developments
- 7.7 Creative Diagnostics
- 7.7.1 Creative Diagnostics Company Information
- 7.7.2 Creative Diagnostics Business Overview
- 7.7.3 Creative Diagnostics Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.7.4 Creative Diagnostics Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.7.5 Creative Diagnostics Recent Developments
- 7.8 Eurofins Technologies
- 7.8.1 Eurofins Technologies Company Information
- 7.8.2 Eurofins Technologies Business Overview
- 7.8.3 Eurofins Technologies Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.8.4 Eurofins Technologies Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.8.5 Eurofins Technologies Recent Developments
- 7.9 IDEXX Laboratories
- 7.9.1 IDEXX Laboratories Company Information
- 7.9.2 IDEXX Laboratories Business Overview
- 7.9.3 IDEXX Laboratories Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.9.4 IDEXX Laboratories Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.9.5 IDEXX Laboratories Recent Developments
- 7.10 Zoetis
- 7.10.1 Zoetis Company Information
- 7.10.2 Zoetis Business Overview
- 7.10.3 Zoetis Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.10.4 Zoetis Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.10.5 Zoetis Recent Developments
- 7.11 QIAGEN
- 7.11.1 QIAGEN Company Information
- 7.11.2 QIAGEN Business Overview
- 7.11.3 QIAGEN Veterinary Infectious Disease Diagnosis Revenue and Gross Margin (2021-2026)
- 7.11.4 QIAGEN Veterinary Infectious Disease Diagnosis Product Portfolio
- 7.11.5 QIAGEN Recent Developments
8 North America
- 8.1 North America Veterinary Infectious Disease Diagnosis Revenue (2021-2032)
- 8.2 North America Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
- 8.2.1 North America Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026)
- 8.2.2 North America Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032)
- 8.3 North America Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032)
- 8.4 North America Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
- 8.4.1 North America Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026)
- 8.4.2 North America Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032)
- 8.5 North America Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032)
- 8.6 North America Veterinary Infectious Disease Diagnosis Revenue by Country
- 8.6.1 North America Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026)
- 8.6.3 North America Veterinary Infectious Disease Diagnosis Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Veterinary Infectious Disease Diagnosis Revenue (2021-2032)
- 9.2 Europe Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
- 9.2.1 Europe Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026)
- 9.2.2 Europe Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032)
- 9.3 Europe Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032)
- 9.4 Europe Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
- 9.4.1 Europe Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026)
- 9.4.2 Europe Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032)
- 9.5 Europe Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032)
- 9.6 Europe Veterinary Infectious Disease Diagnosis Revenue by Country
- 9.6.1 Europe Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026)
- 9.6.3 Europe Veterinary Infectious Disease Diagnosis Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Veterinary Infectious Disease Diagnosis Revenue (2021-2032)
- 10.2 China Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
- 10.2.1 China Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026)
- 10.2.2 China Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032)
- 10.3 China Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032)
- 10.4 China Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
- 10.4.1 China Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026)
- 10.4.2 China Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032)
- 10.5 China Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Veterinary Infectious Disease Diagnosis Revenue (2021-2032)
- 11.2 Asia Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
- 11.2.1 Asia Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026)
- 11.2.2 Asia Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032)
- 11.3 Asia Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032)
- 11.4 Asia Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
- 11.4.1 Asia Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026)
- 11.4.2 Asia Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032)
- 11.5 Asia Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032)
- 11.6 Asia Veterinary Infectious Disease Diagnosis Revenue by Country
- 11.6.1 Asia Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026)
- 11.6.3 Asia Veterinary Infectious Disease Diagnosis Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Veterinary Infectious Disease Diagnosis Revenue (2021-2032)
- 12.2 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2032)
- 12.2.1 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Type (2021-2026)
- 12.2.2 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Type (2027-2032)
- 12.3 SAMEA Veterinary Infectious Disease Diagnosis Revenue Share by Type (2021-2032)
- 12.4 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2032)
- 12.4.1 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Application (2021-2026)
- 12.4.2 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Application (2027-2032)
- 12.5 SAMEA Veterinary Infectious Disease Diagnosis Revenue Share by Application (2021-2032)
- 12.6 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country
- 12.6.1 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country (2021-2026)
- 12.6.3 SAMEA Veterinary Infectious Disease Diagnosis Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst